Inventor · disambiguated record
Hiroko Tanaka
Also filed as: TANAKA HIROKO
61 granted patents·21 pending applications·494 citations·filing 1995–2024
99Inventor score
Top patents by PatentIndex Score
82 records- 0198US9834545B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2016·Granted Dec 5, 2017·26 cites·33 claims
- 0297US11530229B2Cyano cyclobutyl compounds for CBL-B inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Dec 20, 2022·12 cites·71 claims
- 0397US11464802B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·14 cites·53 claims
- 0497US11401267B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2020·Granted Aug 2, 2022·11 cites·32 claims
- 0597US10035768B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Jul 31, 2018·23 cites·10 claims
- 0697US9809581B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2016·Granted Nov 7, 2017·23 cites·29 claims
- 0797US9573897B2C5AR antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Feb 21, 2017·24 cites·9 claims
- 0896US11478460B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2020·Granted Oct 25, 2022·3 cites·34 claims
- 0996US10562896B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Feb 18, 2020·11 cites·38 claims
- 1096US8906938B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2013·Granted Dec 9, 2014·28 cites·5 claims
- 1195US10660897B2C5aR antagonistsCHEMOCENTRYX INC·Filed 2018·Granted May 26, 2020·6 cites·5 claims
- 1295US9783540B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2016·Granted Oct 10, 2017·7 cites·45 claims
- 1395US9126939B2C5AR antagonistsFAN PINGCHEN·Filed 2011·Granted Sep 8, 2015·30 cites·4 claims
- 1495US8445515B2C5aR antagonistsFAN PINGCHEN·Filed 2009·Granted May 21, 2013·38 cites·25 claims
- 1594US11951133B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·36 claims
- 1694US10464934B2Substituted tetrahydropyrans as CCR2 modulatorsCHEMOCENTRYX INC·Filed 2017·Granted Nov 5, 2019·5 cites·13 claims
- 1794US10370363B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2017·Granted Aug 6, 2019·6 cites·13 claims
- 1894US10336736B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2017·Granted Jul 2, 2019·6 cites·24 claims
- 1994US9745268B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2015·Granted Aug 29, 2017·11 cites·31 claims
- 2093US11384079B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2019·Granted Jul 12, 2022·5 cites·18 claims
- 2193US10828285B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2018·Granted Nov 10, 2020·5 cites·27 claims
- 2293US10266492B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2017·Granted Apr 23, 2019·8 cites·10 claims
- 2393US7767687B2Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitorsBIOGEN IDEC INC·Filed 2005·Granted Aug 3, 2010·28 cites·60 claims
- 2492US12485144B23-substituted piperidine compounds for Cbl-b inhibition, and use thereofNURIX THERAPEUTICS INC·Filed 2024·Granted Dec 2, 2025·1 cites·40 claims
- 2592US12049471B2Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Jul 30, 2024·1 cites·16 claims
- 2691US10988464B2Modulators of chemokine receptorsCHEMOCENTRYX INC·Filed 2019·Granted Apr 27, 2021·3 cites·16 claims
- 2790US12234230B2Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2022·Granted Feb 25, 2025·1 cites·5 claims
- 2890US11040960B2Inhibitors of CXCR2CHEMOCENTRYX INC·Filed 2019·Granted Jun 22, 2021·3 cites·14 claims
- 2989US10759789B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2019·Granted Sep 1, 2020·2 cites·27 claims
- 3089US10532982B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2019·Granted Jan 14, 2020·4 cites·1 claims
- 3189US10421748B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2018·Granted Sep 24, 2019·3 cites·43 claims
- 3287US9750722B2Diazole amidesCHEMOCENTRYX INC·Filed 2015·Granted Sep 5, 2017·5 cites·23 claims
- 3386US11434230B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2020·Granted Sep 6, 2022·1 cites·14 claims
- 3485US10744118B2Diazole lactamsCHEMOCENTRYX INC·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
- 3585US9169248B2Diazole amidesCHEMOCENTRYX INC·Filed 2013·Granted Oct 27, 2015·6 cites·22 claims
- 3684US7968536B2Heterocyclic compounds useful as RAF kinase inhibitorsMILLENNIUM PHARM INC·Filed 2008·Granted Jun 28, 2011·9 cites·31 claims
- 3783US12139475B22-oxindole compoundsCHEMOCENTRYX INC·Filed 2022·Granted Nov 12, 2024·0 cites·4 claims
- 3883US9328116B2Diazole lactamsCHEMOCENTRYX INC·Filed 2013·Granted May 3, 2016·4 cites·4 claims
- 3983US2023102258A1C5ar antagonistsCHEMOCENTRYX INC·Filed 2022·Application pending·0 cites
- 4081US9340509B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2014·Granted May 17, 2016·4 cites·17 claims
- 4181US8802657B2Compounds useful as Raf kinase inhibitorsMILLENNIUM PHARM INC·Filed 2012·Granted Aug 12, 2014·4 cites·19 claims
- 4281US2025136590A1Substituted benzyl-triazole compounds for cbl-b inhibition, and further uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4380US9795599B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2016·Granted Oct 24, 2017·2 cites·24 claims
- 4480US8293752B2Compounds useful as Raf kinase inhibitorsCHEN WEIRONG·Filed 2008·Granted Oct 23, 2012·6 cites·13 claims
- 4580US2024409555A1Cyano cyclobutyl compounds for cbl-b inhibition and uses thereofNURIX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4679US11845729B2Processes and intermediates in the preparation of C5aR antagonistsCHEMOCENTRYX INC·Filed 2022·Granted Dec 19, 2023·0 cites·10 claims
- 4778US10117865B2CCR6 compoundsCHEMOCENTRYX INC·Filed 2017·Granted Nov 6, 2018·1 cites·6 claims
- 4875US12268675B2Diaryl substituted 6,5-fused ring compounds as C5aR inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Apr 8, 2025·0 cites·16 claims
- 4975US11773091B26-5 fused rings as C5a inhibitorsCHEMOCENTRYX INC·Filed 2022·Granted Oct 3, 2023·0 cites·20 claims
- 5075US5990346AProstaglandins and processes for production thereofTEIJIN LTD·Filed 1996·Granted Nov 23, 1999·19 cites·13 claims
Showing the top 50 of 82 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hiroko Tanaka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →